Osterweis Capital Management Inc Summit Therapeutics Inc. Transaction History
Osterweis Capital Management Inc
- $1.67 Billion
- Q3 2024
A detailed history of Osterweis Capital Management Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Osterweis Capital Management Inc holds 5,000 shares of SMMT stock, worth $93,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$93,350
Previous $39,000
179.49%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$456 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$147 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$102 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$64.8 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.76B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...